文献速递湿疹皮炎与荨麻疹

远程识别新发儿童特应性皮炎:CASCADE预防试验诊断方法的比较

Remote identification of new onset pediatric atopic dermatitis - a comparison of diagnostic methods from a post-hoc analysis of the CASCADE prevention trial.
PubMed 文献 · Br J Dermatol · 2026-08-26

该研究基于CASCADE预防试验的事后分析,在933名≤2岁儿童中评估童年湿疹问卷与临床医生AD诊断代理报告对远程诊断特应性皮炎的表现,以临床医生病历诊断(24月龄时占26.2%)为参考标准。结果显示临床医生AD诊断代理报告在12和24月龄的敏感度/特异度分别为65.8%/91.3%和71.6%/93.2%,优于童年湿疹问卷。

要点

  • 临床医生AD诊断代理报告在24月龄敏感度71.6%、特异度93.2%。
  • 童年湿疹问卷在24月龄敏感度50.9%、特异度93.2%。
  • 代理报告未观察到瘙痒或皮疹是问卷假阴性最常见原因。

核心结论

  • 临床医生AD诊断代理报告在远程识别≤2岁儿童特应性皮炎中表现良好,优于童年湿疹问卷。

研究设计与样本

  • CASCADE预防试验的事后分析,纳入933名≤2岁儿童,以临床医生病历诊断AD为参考标准(24月龄时26.2%)。

主要发现

  • 临床医生AD诊断代理报告12月龄敏感度65.8%、特异度91.3%,24月龄敏感度71.6%、特异度93.2%。
  • 临床医生AD诊断代理报告12月龄阳性预测值72.5%、阴性预测值88.5%,24月龄阳性预测值88.3%、阴性预测值82.2%。
  • 童年湿疹问卷12月龄敏感度46.3%、特异度91.5%、阳性预测值64.5%、阴性预测值83.5%,24月龄分别为50.9%、93.2%、84.1%、72.8%。
  • 童年湿疹问卷假阴性最常见原因是代理报告未观察到或未报告瘙痒或皮疹。

关键数值与推荐

  • 临床医生AD诊断代理报告在24月龄的敏感度71.6%、特异度93.2%、阳性预测值88.3%、阴性预测值82.2%。
  • 童年湿疹问卷在24月龄的敏感度50.9%、特异度93.2%、阳性预测值84.1%、阴性预测值72.8%。

临床怎么用

  • 在≤2岁有医疗资源的儿童中,临床医生AD诊断代理报告可作为远程研究识别湿疹病例的合适方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few validated diagnostic criteria for atopic dermatitis (AD) can diagnose AD without a clinician's exam, and even fewer are validated in very young children. Recently, the Community-based Assessment of Skin Care, Allergies, and Eczema (CASCADE) prevention trial remotely captured parent/caregiver responses to the Childhood Eczema Questionnaire and a Proxy Report of a Clinician AD Diagnosis in children ≤2 years of age. OBJECTIVES: To evaluate the performance of Childhood Eczema Questionnaire and Proxy Report of a Clinician AD Diagnosis for the purpose of remote AD diagnosis. METHODS: Data from the CASCADE trial was used to calculate the sensitivity, specificity, positive predictive value, and negative predictive value of Childhood Eczema Questionnaire or Proxy Report of a Clinician AD Diagnosis at 12 and 24 months of age in 933 participants with data available for comparison against the reference standard of a clinician's chart diagnosis of AD, present in 26.2% (244/933 at 24 months) of the cohort. Clinicians who acted as the reference standard were primary care clinicians or pediatricians who received additional training in diagnosing AD. RESULTS: Proxy Report of a Clinician AD Diagnosis displayed sensitivity/specificity at 12 months (65.8%/91.3%) and 71.6%/93.2% at 24 months. It also displayed positive and negative predictive values of 72.5%/88.5% at 12 months and 88.3%/82.2% 24 months. The Childhood Eczema Questionnaire showed sensitivity, specificity, positive and negative predictive values of 46.3%/91.5%/64.5%/83.5% at 12 months and 50.9%/93.2%/84.1%/72.8% at 24 months. A lack of proxy-observed or reported itch or rash were the most common reasons for Childhood Eczema Questionnaire false negative cases. CONCLUSIONS: Proxy Report of a Clinician AD Diagnosis performed well for sensitivity, specificity, positive and negative predictive values, followed by Childhood Eczema Questionnaire. This U.S. study provides new evidence that supports Proxy Report of a Clinician AD Diagnosis as an adequate approach to identify eczema cases remotely for research in children <2 with access to healthcare.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Fang MM, Gillespie J, Okereke R, et al. Remote identification of new onset pediatric atopic dermatitis - a comparison of diagnostic methods from a post-hoc analysis of the CASCADE prevention trial. Br J Dermatol. 2026. PMID: 42644483. doi:10.1093/bjd/ljag347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。